Skip to main content
NCBI home page
Journal of the Royal Society of Medicine logoLink to Journal of the Royal Society of Medicine
. 1994 Nov;87(11):652–654. doi: 10.1177/014107689408701105

National industry's interest in colorectal cancer screening programmes.

A R Hart 1, T L Barone 1, A C Wicks 1, J F Mayberry 1
PMCID: PMC1294927  PMID: 7837182

Abstract

The interest of the largest 200 British industries in developing and financing colorectal screening services for employees was determined. A standard questionnaire asked if the company would advertise screening supply names of employees to local hospitals and finance faecal occult blood testing. The reasons for rejection were noted. Eighty-six companies returned the questionnaire (43% response rate) of which 78 firms (39% of the total mailed) were prepared to advertise screening programmes at the workplace. A quarter of the companies were prepared to both advertise and release employee details. Companies willing to participate employed significantly more people (mean of 17,000 employees) than those rejecting screening (mean of 6100 employees, Mann-Whitney U test = 7, P < 0.05). Fifty-nine industries would consider financing screening, although only five made a definite decision to do so. All companies rejecting (36/36) were concerned about releasing employee information to hospitals. If screening does reduce mortality and community programmes are developed industry could and is prepared to advertise such programmes. If a partnership between hospitals and industry is developed, concerns about employee confidentiality needs to be addressed.

Full text

PDF
652

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Acquavella J. F., Douglass T. S., Phillips S. C. Evaluation of excess colorectal cancer incidence among workers involved in the manufacture of polypropylene. J Occup Med. 1988 May;30(5):438–442. doi: 10.1097/00043764-198805000-00012. [DOI] [PubMed] [Google Scholar]
  2. Farrands P. A., Griffiths R. L., Britton D. C. The Frome experiment--value of screening for colorectal cancer. Lancet. 1981 Jun 6;1(8232):1231–1232. doi: 10.1016/s0140-6736(81)92401-6. [DOI] [PubMed] [Google Scholar]
  3. Hardcastle J. D., Thomas W. M., Chamberlain J., Pye G., Sheffield J., James P. D., Balfour T. W., Amar S. S., Armitage N. C., Moss S. M. Randomised, controlled trial of faecal occult blood screening for colorectal cancer. Results for first 107,349 subjects. Lancet. 1989 May 27;1(8648):1160–1164. doi: 10.1016/s0140-6736(89)92750-5. [DOI] [PubMed] [Google Scholar]
  4. Hart A. R., Wicks A. C., Mayberry J. F. A survey of industries and colorectal cancer screening of employees in the East Midlands of England. J R Soc Med. 1993 Oct;86(10):571–572. doi: 10.1177/014107689308601009. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Heyden S., Fodor J. G. Industrial cancer education and screening for 19,000 Cannon Mills employees. J Chronic Dis. 1981;34(5):225–231. doi: 10.1016/0021-9681(81)90066-7. [DOI] [PubMed] [Google Scholar]
  6. Kronborg O., Fenger C., Søndergaard O., Pedersen K. M., Olsen J. Initial mass screening for colorectal cancer with fecal occult blood test. A prospective randomized study at Funen in Denmark. Scand J Gastroenterol. 1987 Aug;22(6):677–686. doi: 10.3109/00365528709011142. [DOI] [PubMed] [Google Scholar]
  7. Lallemand R. C., Vakil P. A., Pearson P., Box V. Screening for asymptomatic bowel cancer in general practice. Br Med J (Clin Res Ed) 1984 Jan 7;288(6410):31–33. doi: 10.1136/bmj.288.6410.31. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Laville E. A., Vernon S. W., Jackson G. L., Hughes J. I. Comparison of participants and nonparticipants in a work site cancer awareness and screening program. J Occup Med. 1989 Mar;31(3):221–232. doi: 10.1097/00043764-198903000-00007. [DOI] [PubMed] [Google Scholar]
  9. Mandel J. S., Bond J. H., Church T. R., Snover D. C., Bradley G. M., Schuman L. M., Ederer F. Reducing mortality from colorectal cancer by screening for fecal occult blood. Minnesota Colon Cancer Control Study. N Engl J Med. 1993 May 13;328(19):1365–1371. doi: 10.1056/NEJM199305133281901. [DOI] [PubMed] [Google Scholar]
  10. Million R., Howarth J., Turnberg E., Turnberg L. A. Faecal occult blood testing for colorectal cancer in general practice. Practitioner. 1982 Apr;226(1366):659–663. [PubMed] [Google Scholar]
  11. Muto T., Bussey H. J., Morson B. C. The evolution of cancer of the colon and rectum. Cancer. 1975 Dec;36(6):2251–2270. doi: 10.1002/cncr.2820360944. [DOI] [PubMed] [Google Scholar]
  12. Neale A. V., Demers R. Y., Herman S. Compliance with colorectal cancer screening in a high-risk occupational group. J Occup Med. 1989 Dec;31(12):1007–1012. doi: 10.1097/00043764-198912000-00015. [DOI] [PubMed] [Google Scholar]
  13. Silman A. J., Mitchell P., Nicholls R. J., Macrae F. A., Leicester R. J., Bartram C. I., Simmons M. J., Campbell P. D., Hearn C. E., Constable P. J. Self-reported dark red bleeding as a marker comparable with occult blood testing in screening for large bowel neoplasms. Br J Surg. 1983 Dec;70(12):721–724. doi: 10.1002/bjs.1800701209. [DOI] [PubMed] [Google Scholar]
  14. Stryker S. J., Wolff B. G., Culp C. E., Libbe S. D., Ilstrup D. M., MacCarty R. L. Natural history of untreated colonic polyps. Gastroenterology. 1987 Nov;93(5):1009–1013. doi: 10.1016/0016-5085(87)90563-4. [DOI] [PubMed] [Google Scholar]
  15. Vernon S. W., Acquavella J. F., Douglass T. S., Hughes J. I. Factors associated with participation in an occupational program for colorectal cancer screening. J Occup Med. 1989 May;31(5):458–463. [PubMed] [Google Scholar]
  16. Williams A. C., Harper S. J., Paraskeva C. Neoplastic transformation of a human colonic epithelial cell line: in vitro evidence for the adenoma to carcinoma sequence. Cancer Res. 1990 Aug 1;50(15):4724–4730. [PubMed] [Google Scholar]

Articles from Journal of the Royal Society of Medicine are provided here courtesy of Royal Society of Medicine Press

RESOURCES